Team experience of nasopharyngeal samples reception,decontamination,and sorting during the COVID-19 pandemic(2020)at Institut Pasteur Côte d’Ivoire

作     者：KouaméInnocent Kolia KipréBertin Guédé Kan Stéphane Kouassi Koby Albert Obro Kpadraux Danielle Odegue Sylvie Mireil Sina-Kouaméle Banga Victor Yepri Mireille Dosso 

作者机构：Molecular Biology Platform/Institut Pasteur Côte d’IvoireCentral Laboratory/University Hospital Center of Yopougon(Côte d’Ivoire)Cote d’Ivoire Bacteriology and Virology DepartmentNational Reference Center for Antibiotics/Institut Pasteur Côte d’IvoireCôte d’Ivoire Molecular Biology Platform/Institut Pasteur Côte d’IvoireCôte d’Ivoire Cell Biology Unit/Institut Pasteur Côte d’IvoireCôte d’Ivoire Transport and packaging unit/Institut Pasteur Côte d’IvoireCôte d’Ivoire Institut Pasteur Côte d’IvoireCôte d’Ivoire 

出 版 物：《Journal of Biosafety and Biosecurity》 (生物安全和生物安保杂志（英文）)

年 卷 期：2021年第3卷第2期

页      面：120-124页

学科分类：0401[教育学-教育学] 04[教育学] 

主　　题：Sorting and decontamination Nasopharyngeal sample COVID-19 Côte d’Ivoire 

摘      要：Molecular testing sensitivity,which allows for early diagnosis of the 2019 coronavirus disease(COVID-19),could be affected by sample quality,storage,and transportation timeframe to the laboratory,along with bias related to the pre-analytic *** present study reports the selection and decontamination of nasopharyngeal samples during COVID-19 management at the Institut Pasteur Côte d’*** objective of this work was to organize sample reception management and report a complete picture of sample selection and decontamination in the context of diagnosis activity *** administrative note creating the selection and decontamination unit of nasopharyngeal samples initiated activities in May *** required human resources and necessary materials were identified and put in *** activity consisted of receiving,sorting,decontaminating,and sending nasopharyngeal samples to different diagnostic *** were recorded *** a six-month period of activities,from a total amount of 11,401 containers received and decontaminated,174,085 samples were selected.A proportion of 92.0%of these specimens met the diagnostic standards,while 7.0%that were found acceptable showed minor ***,a rate of 1.0%of samples with major abnormalities could not be used for COVID-19 testing and,therefore,were ***,the non-conformity rate was reduced by 2.4%after the first term *** and decontamination of nasopharyngeal samples are crucial steps in biosafety optimization for the technical staff and quality improvement of sample care.